Throughout the school year, 38 junior and senior secondary school students have been hosted each month in 9 neuroscience laboratories specialising in addiction studies. The aim: to change the views of the young “Novice Researchers” on the hidden face of drugs (alcohol, tobacco, cannabis, etc.) and addiction, and to educate them about research methods and research careers. From 1 June next, the Novice Researchers will present their research at 5 conferences organised in Marseille (1 June), Amiens (2 June), Paris (3 June), Bordeaux (4 June) and Poitiers (9 June).
The MAAD (Mechanisms of Addiction to Alcohol and Drugs) programme, launched by Inserm with the support of MILDECA (French Government Interministerial Mission for Combating Drugs and Addictive Behaviours), is based on a “scientific education” style approach, intended to increase the knowledge of young people on these substances by introducing them to the scientific method.
Nine research laboratories specialising in addiction physiopathology hosted, on one Wednesday each month, two “binomes,” pairs comprising one final year junior secondary school student and one second year senior secondary school student. Mentored by a senior researcher, the adolescents conducted a research project, performed experiments and interpreted data.
The conferences organised in the different research centres involved will enable these young Novice Researchers to share their results. The audience will be made up of their classmates, parents, teachers, etc.
♦ In Paris, the conference will be held on Wednesday, 3 June 2015 at 6:00 pm, at the Ministry of Agriculture, Gambetta Room (78 rue de Varennes, Paris 5th Arrondissement)
Registration required, via acmaad.tumblr.com or by contacting firstname.lastname@example.org
Danièle Jourdain-Menninger, President of MILDECA, will open the event
The Novice Researchers’ presentations will be followed by a talk and discussion entitled “Nicotine et Prise de Décision” (Nicotine and Decision-Making), led by Philippe Faure, a CNRS researcher at UMR 7102.
♦ Marseille, Monday 1 June, 6:30 pm
♦ Amiens, Tuesday 2 June, 6:00 pm
♦ Bordeaux, Thursday 4 June, 6:30 pm
♦ Poitiers, Tuesday, 9 June, 6:00 pm
These conferences are open to all and admission is free.
 The 9 participating laboratories are as follows: Amiens: Inserm ERI 24, Prof. Mickaël Naassila; Bordeaux: Inserm U862 Neurosciences Magendie, Véronique Deroche; CNRS UMR 5287, Martine Cador / Stéphanie Caillé-Garnier; Marseille: Mediterranean Institute of Neurobiology (INMED), Olivier Manzoni; UMR 7289 CNRS Cognitive Neurobiology Laboratory, Christelle Baunez; Paris: Inserm UMR 894, Laurence Lanfumey, Nicolas Ramoz; Inserm UMR-S 839 Institut du Fer à Moulin, Denis Hervé, Marika Nosten-Bertrand, Manuel Mameli; CNRS UMR 7102, Philippe Faure; Poitiers: Inserm U1084 Experimental and Clinical Neurosciences Laboratory, Marcello Solinas.
Les deux bras testant la combinaison lopinavir/ritonavir avec ou sans interféron bêta sont arrêtés dans les essais cliniques Solidarity et Discovery. Compte tenu de la nature adaptative des deux essais, une réflexion est en cours sur l'évolution du protocole. Des publications dans ...
The CNRS and Inserm, in association with the CPU, INED, INRAE and IRD, under the umbrella of ATHENA and AVIESAN1, are joining forces to raise key scientific questions on health and environmental crises and combine the initiatives of the humanities, social sciences ...